06:05 PM EST, 12/02/2024 (MT Newswires) -- Korro Bio ( KRRO ) filed a registration statement Monday with the US Securities and Exchange Commission covering the potential sale of up to $400 million of its securities from time to time.

The filing covers a base prospectus for up to $400 million of debt securities, common stock, preferred stock, units, and warrants in one or more offerings, including an "at the market offering" of up to $100 million of common shares under a sales agreement with TD Securities.

Proceeds will be used for general corporate purposes.